What is the recommended dosage and duration of treatment for tinea (fungal infection) around the lips and cheeks in a 10-year-old female patient weighing 35 kilograms and a 5-year-old male patient weighing 18 kilograms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Tinea Around Lips and Cheeks in Pediatric Patients

For tinea infections around the lips and cheeks (tinea faciei), topical antifungal therapy alone is appropriate and effective, unlike scalp infections which require systemic treatment. 1

Recommended Topical Treatment Regimen

Apply terbinafine 1% cream once daily for 1-2 weeks for both children. 2 This fungicidal agent provides high cure rates with short treatment duration and is well-tolerated in pediatric patients ages 2-15 years. 2

Dosing for Both Patients:

  • 10-year-old female (35 kg): Terbinafine 1% cream applied once daily to affected areas
  • 5-year-old male (18 kg): Terbinafine 1% cream applied once daily to affected areas

The dosing is the same regardless of weight for topical therapy, as absorption is minimal and treatment is based on affected surface area. 2

Treatment Duration and Monitoring

Continue treatment for at least 1 week after complete clinical resolution to ensure mycological cure. 1 This typically means:

  • Minimum treatment duration: 1 week of daily application 2
  • Total duration: Continue for 1 additional week after lesions clear (usually 2-3 weeks total) 1
  • Reassessment point: If no improvement after 2 weeks, reassess diagnosis or consider oral antifungal therapy 1

Clinical improvement should be evident within the first week, with efficacy rates of 92% for complete cure or significant improvement. 2

Critical Adjunctive Measures

Implement these infection control measures to prevent treatment failure and reinfection:

  • Wash hands thoroughly after applying medication 1, 3
  • Do not share towels, clothing, or bedding between family members 1
  • Wash all clothing, bedding, and towels in hot water 1, 3
  • Screen and treat family members showing signs of infection 1, 3

When Systemic Therapy Is Required

Consider oral antifungal therapy if:

  • No improvement after 2 weeks of appropriate topical treatment 1
  • Extensive or severe infection
  • Immunocompromised status
  • Recurrent infections despite adequate topical therapy

If systemic therapy becomes necessary, the choice depends on the causative organism (though this is rarely identified in facial tinea):

For Trichophyton species (most common):

  • Terbinafine:
    • 18 kg child: 62.5 mg daily for 2-4 weeks 4
    • 35 kg child: 125 mg daily for 2-4 weeks 4

For Microsporum species (less common):

  • Griseofulvin:
    • Both children (<50 kg): 15-20 mg/kg/day for 6-8 weeks 4
    • 18 kg child: 270-360 mg daily
    • 35 kg child: 525-700 mg daily

Common Pitfalls to Avoid

Do not discontinue treatment when symptoms improve but before completing the full course plus one additional week. 1 This is the most common cause of treatment failure and recurrence. 1, 3

Do not fail to address environmental contamination. Fungal spores persist on fomites and cause reinfection even with successful initial treatment. 1, 3

Do not assume treatment failure without ensuring compliance. Verify that medication is being applied daily and that infection control measures are being followed. 4

Adverse Effects Monitoring

Topical terbinafine is well-tolerated with minimal side effects. In pediatric studies, adverse reactions included itching (3%), itching with erythema (1%), and contact dermatitis (1%). 2 These are generally mild and do not require treatment discontinuation.

References

Guideline

Topical Antifungal Treatment for Ringworm

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Diaper Candidal Dermatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.